(Q42407045)

29 October 2017

0 references

Hepatitis C: the end of the beginning and possibly the beginning of the end. (English)

1 reference

29 October 2017

1 reference

1

Harvey J Alter

1 reference

29 October 2017

T Jake Liang

2

1 reference

PMC publication ID

3480337

29 October 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

Annals of Internal Medicine

29 October 2017

1 reference

29 October 2017

156

1 reference

29 October 2017

4

1 reference

29 October 2017

317-318

1 reference

New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Telaprevir for retreatment of HCV infection

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Boceprevir for untreated chronic HCV genotype 1 infection

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

The hepatitis C virus life cycle as a target for new antiviral therapies

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Peginterferon and ribavirin for chronic hepatitis C.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Institute of Medicine recommendations for the prevention and control of hepatitis B and C.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480337

Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22351718

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7326/0003-4819-156-4-201202210-00014

1 reference

29 October 2017

1 reference

PMC publication ID

3480337

29 October 2017

PubMed publication ID

22351718

1 reference

PMC publication ID

3480337